Assistance program
Research and Data Analysis
$19.1 Million committed in FY2018–FY2026
- Agency
- Executive Office of the President, Executive Office of the President
- Assistance
- Cooperative Agreements
- CFDA number
- 95.007
- What it does
- The purpose of research and data analysis is to inform policy formulation and assessment. The work involves research and analysis of data as it pertains to drug policy.
- Who benefits
- Applicants must have expert knowledge and extensive experience in conducting research and analysis.
- Who applies
- Applicants must have expert knowledge and extensive experience in conducting research and analysis.
- Authorized by
- Reauthorization of the Office of National Drug Control Policy (ONDCP), Public Law 115-271
- Program site
- https://www.whitehouse.gov/ONDCP ↗
Committed by fiscal year
* FY2026 is year-to-date — the fiscal year is still in progress, so its total is still filling in. The striped band and dashed line mark that provisional stretch.
Top recipients
By dollars committed.
Administering agencies
By dollars committed.
How to read these numbers
- Committed through this program
Money committed under this assistance listing (its CFDA program), counted in the year each action happened.
- How it's paid
Most programs pay out one way — a grant, or a direct payment to individuals; the flow bar only appears when a program genuinely mixes types.
- Some recipients aren't itemized
For entitlement programs like Social Security and Medicare, the government reports one aggregate instead of naming tens of millions of people, so the recipient roster isn't part of the public record.
- Awards, counted once
An award count is the number of distinct awards with at least one action that year — each counted once, however many times it was amended.
- The colored bars
Every bar on this page splits by how the money moves:
Direct payments